![Foto de Miriam](/img/nophoto.png)
Miriam
Estébanez Muñoz
Profesor/a Asociado/a en CC. de la Salud
Publicacións (52) Publicacións de Miriam Estébanez Muñoz
2023
-
Patterns of Sexualized Drug Use among Gay, Bisexual, and Other Men Who Have Sex with Men Living with HIV: Insights from a Comprehensive Study—The U-SEX-2 GESIDA 9416 Study
Journal of Clinical Medicine, Vol. 12, Núm. 23
-
The Impact of Antibiotic Prophylaxis on a Retrospective Cohort of Hospitalized Patients with COVID-19 Treated with a Combination of Steroids and Tocilizumab
Antibiotics, Vol. 12, Núm. 10
-
Treatment and prevention of monkeypox
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 10, pp. 629-634
2022
-
Dolor e impotencia funcional en miembro inferior derecho
Colección de casos clínicos cerrados de la Facultad de Medicina y Ciencias de la Salud. Universidad de Alcalá (2020-2021) (Servicio de Publicaciones), pp. 73-86
2021
-
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study
The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792
2020
-
Aspectos cardiológicos relevantes en la infección COVID-19
RIECS: Revista de Investigación y Educación en Ciencias de la Salud, Vol. 5, Núm. 1, pp. 121-133
-
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
Clinical Microbiology and Infection, Vol. 26, Núm. 11, pp. 1525-1536
-
Incidence, characteristics, laboratory findings and outcomes in acro-ischemia in covid-19 patients
Vascular Health and Risk Management, Vol. 16, pp. 467-478
-
Organización de la cuarentena hospitalaria en los evacuados de Wuhan al inicio de la pandemia de COVID-19
Sanidad militar: revista de sanidad de las Fuerzas Armadas de España, Vol. 76, Núm. 2, pp. 79-84
-
Physicians' opinions on generic antiretroviral drugs and single-tablet regimen de-simplification for the treatment of HIV infection: A multicentre survey in Spain
Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 2, pp. 466-472
-
Randomised multicentre clinical trial to evaluate voriconazole pre-emptive genotyping strategy in patients with risk of aspergillosis: vorigenipharm study protocol
BMJ open, Vol. 10, Núm. 10, pp. e037443
2019
-
Más allá del ecocardiograma en el diagnóstico de la insuficiencia cardiaca
RIECS: Revista de Investigación y Educación en Ciencias de la Salud, Vol. 4, Núm. 1, pp. 15-19
-
Safety and efficacy of prolonged use of dalbavancin in bone and joint infections
Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 5
-
Use of ribavirin in viruses other than hepatitis C. A review of the evidence
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 9, pp. 602-608
2018
-
Lemierre's syndrome. Report of a case with pulmonary and muscular septic embolisms and literature review
Revista de Patologia Respiratoria, Vol. 21, Núm. 2, pp. 67-70
2017
-
Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach
PLoS ONE, Vol. 12, Núm. 9
-
Simplification to dual therapy (atazanavir/ritonavir1lamivudine) versus standard triple therapy [atazanavir/ritonavir1two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 1, pp. 246-253
2016
-
Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013
Journal of Infection, Vol. 72, Núm. 5, pp. 587-596
-
MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression
PLoS ONE, Vol. 11, Núm. 5
-
Relationship between plasma bilirubin level and oxidative stress markers in HIV-infected patients on atazanavir- vs. efavirenz-based antiretroviral therapy
HIV Medicine, Vol. 17, Núm. 9, pp. 653-661